October 1, 2018

I just received the following email from the lead scientist on the linked research from above. Now a new mystery to solve. It seems he worked in the exact same group I went to at MD Anderson (years ago) and he says they were researching athelmintics, and specifically Fenbendazole, for cancer way back then. Things that make you go Hmmm


o SubjectResponse to your comment on our work published in Scientific Reports

o Message

Hi Joe,

Thanks for sharing your remarkable story with us. It is indeed a source of greatest joy for any researcher when his/her work is able to contribute in alleviating someone’s suffering to the slightest extent.

Our earlier work in 2002 on Mebendazole (an anthelmintic drug for pinworm infection approved for use in humans) revealed its potential application as an anti-cancer agent while I was working at the department of Thoracic Surgery in MD Anderson Cancer Center.

(1,2) In our present report and our previous work (3), we provided sufficient pre-clinical data on the anti-cancer effect of fenbendazole (FZ) using mouse models. It is very encouraging for us to know its significant effect on a patient diagnosed with metastatic lung cancer. For how long did you take fenbendazole? Did you experience any side effects? Are you still taking FZ or any other drug? We strongly believe that anthelmintic drugs can effectively inhibit the tumor cell growth which has a long safety track record. In our preclinical studies we have shown that it is as effective as cisplatin and related chemotherapeutic drugs with least toxicity to the host. Please keep in touch and let us know if you have any new information. Thank you once again for your efforts in bringing awareness about the anti-cancer effect of FZ through your blog.

Wishing you a long disease free healthy life!


Tapas Mukhopadhyay